The expression levels of thrombospondin-1 in dermatofibroma and dermatofibrosarcoma protuberans

European Journal of Dermatology

Volumn 21, Issue 4, 2011, Pages 534-538

  Maekawa, Takeo ^a   Jinnin, Masatoshi ^b   Ihn, Hironobu ^b  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Differential diagnosis; Immunoblotting; Immunohistochemical analysis

Indexed keywords

THROMBOSPONDIN 1; TRANSFORMING GROWTH FACTOR BETA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DERMATOFIBROMA; DERMATOFIBROSARCOMA PROTUBERANS; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MALE; MOLECULAR PATHOLOGY; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; SKIN APPENDAGE;

ADULT; DERMATOFIBROSARCOMA; FEMALE; HISTIOCYTOMA, BENIGN FIBROUS; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; THROMBOSPONDIN 1;

EID: 80053045254     PISSN: 11671122     EISSN: 19524013     Source Type: Journal    
DOI: 10.1684/ejd.2011.1392     Document Type: Article

References (23)

1. Heenan PJ. Tumors of the fibrous tissue involving the skin. In: Elder D, Elenitsas R, Jaworsky C, Johnson B, eds, Lever's histopathology of the skin, 8th edn. Philadelphia: Lippincot-Raven, 1997: 847-87.
2. Peters CW, Hanke CW, Pasarell HA, Bennett JE. Chemosurgical reports. Dermatofibrosarcoma protuberans of the face. J Dermatol Surg Oncol 1982; 8: 823-6.
3. Gutierrez G, Ospina JE, de Baez NE, et al. Dermatofibrosarcoma protuberans. Int J Dermatol 1984; 23: 396-401.
4. Kahn LB, Saxe N, Gordon W. Dermatofibrosarcoma protuberans with lymph node and pulmonary metastases. Arch Dermatol 1978; 114: 599-601.
5. Berbis P, Devant O, Echinard C, et al. Metastatic Darier-Ferrand dermatofibrosarcoma. Review of the literature apropos of a case. Ann Dermatol Venereol 1987; 114: 1217-27.
6. Kamino H, Jacobson M. Dermatofibroma extending into the subcutaneous tissue. Differential diagnosis from dermatofibrosarcoma protuberans. Am J Surg Pathol 1990; 14: 1156-64.
7. Lautier R, Wolff HH, Jones RE. An immunohistochemical study of dermatofibrosarcoma protuberans supports its fibroblastic character and contradicts neuroectodermal or histiocytic components. Am J Dermatopathol 1990; 12: 25-30.
8. Ma CK, Zarbo RJ, Gown AM. Immunohistochemical characterization of atypical fibroxanthoma and dermatofibrosarcoma protuberans. Am J Clin Pathol 1992; 97: 478-83.
9. Calonje E, Mentzel T, Fletcher CD. Cellular benign fibrous histiocytoma. Clinicopathologic analysis of 74 cases of a distinctive variant of cutaneous fibrous histiocytoma with frequent recurrence. Am J Surg Pathol 1994; 18: 668-76.
10. Cohen PR, Rapini RP, Farhood AI. Expression of the human hematopoietic progenitor cell antigen CD34 in vascular and spindle cell tumors. J Cutan Pathol 1993; 20: 15-20.
11. LeRoy EC, Smith EA, Kahaleh MB, et al. A strategy for determining the pathogenesis of systemic sclerosis; is transforming growth factor _ the answer? Arthritis Rheum 1989; 32: 817-25.
12. Massague J. The transforming growth factor-_ family. Annu Rev Cell Biol 1990; 6: 597-641.
13. Border WA, Noble NA. Transforming growth factor b in tissue fibrosis. N Engl J Med 1994; 331: 1286-92.
14. Anns JP, Munger JS, Rifkin DB. Making sense of latent TGF-β activation. J Cell Sci 2003; 116: 217-24.
15. Crawford SE, Stellmach V, Murphy-Ullrich JE, et al. Thrombospondin-1 is a major activator of TGF_ in vivo. Cell 1998; 93: 1159-70.
16. Adams JC. Thrombospondin-1. Int J Biochem Cell Biol 1997; 29: 861-5.
17. Schultz-Cherry S, Lawler J, Murphy-Ullrich JE. The type 1 repeats of thrombospondin-1 activate latent transforming growth factor-_. J Biol Chem 1994; 269: 26783-8.
18. Schultz-Cherry S, Chen H, Mosher DF, et al. Regulation of transforming growth factor-_ activation by discrete sequences of thrombospondin-1. J Biol Chem 1995; 270: 7304-10.
19. Ribiero SMF, Poczatek M, Schultz-Cherry C, Villian M, Murphy-Ullrich JE. The activation sequence of thrombospondin-1 interacts with the latency-associated peptide to regulate activation of latent transforming growth factor-_. J Biol Chem 1999; 274: 13586-93.
20. Barnes JL, Mitchell RJ, Kanalas JJ, Barnes VL. Differential expression of thrombospondin and cellular fibronectin during remodeling in proliferative glomerulonephritis. J Histochem Cytochem 1999; 47: 533-44.
21. Hugo C, Shanklad S, Pichler RH, Couser WG, Johnson RJ. thrombospondin-1 precedes and predicts the development of tubulointerstitial fibrosis in glomerular disease in the rat. Kidney Int 1998; 53: 302-11.
22. Mimura Y, Ihn H, Jinnin M, Asano Y, Yamane K, Tamaki K. Constitutive thrombospondin-1 overexpression contributes to autocrine transforming growth factor-_ signaling in cultured scleroderma fibroblasts. Am J Pathol 2005; 166: 1451-63.
23. Meister P, Konrad E, Hohne N. Incidence and histological structure of the storiform pattern in benign and malignant fibrous histiocytomas. Virchows Arch A Pathol Anat Histol 1981; 393: 93-101.